Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Clearbridge Health Ltd. (1H3) Share Price & Analysis

3 Followers

1H3 Stock Chart & Stats

S$0.00S$0.00(0.00%)
At close: 4:58 PM GMT+8
S$0.01S$0.011S$0.012Sep 25Oct 9Oct 17Dec 18
Day’s Range
SGD 0.01 - SGD 0.01
52-Week Range
SGD 0.01 - SGD 0.02
Previous Close
SGD 0.01
Volume
N/A
Average Volume (3M)
2.87M
Market Cap
SGD 6.44M
Enterprise Value
SGD 5.52M
Total Cash (Recent Filing)
SGD 4.12M
Total Debt (Recent Filing)
SGD 703.00K
Price to Earnings (P/E)
―
Beta
0.15
Next Earnings
Aug 18, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Rebound

The 2025 revenue rebound indicates renewed demand for the company’s diagnostic and screening services after earlier weakness. If maintained, a larger revenue base could improve operating leverage, support investment in service capacity, and provide a foundation for restoring profitability over the next several quarters.

Manageable Leverage

Debt remained modest relative to equity in the latest year, limiting balance-sheet pressure compared with a highly leveraged healthcare operator. This provides some financial flexibility to manage operations and pursue the existing business model, although continuing losses could weaken that position over time.

Diagnostics Platform

Clearbridge operates in healthcare diagnostics and screening, services that are delivered through an established network of facilities and partner channels. This operating platform gives the company defined capabilities and routes to patients, supporting ongoing participation in a recurring healthcare-services market.

Bears Say

Persistent Net Losses

Persistent losses, including a substantial widening in 2025, show that revenue growth has not yet translated into a sustainable earnings model. Continued losses can constrain reinvestment, weaken financial resilience, and make future performance increasingly dependent on a successful reduction in operating costs.

Ongoing Cash Burn

Negative operating and free cash flow across five consecutive years indicates that the business has not funded its operations internally. Even with improvement in 2025 free cash flow, continued cash consumption may increase reliance on external funding and limit the company’s ability to invest or absorb further losses.

Weakened Balance Sheet

Declining equity and assets indicate that sustained losses have reduced the company’s financial base and shareholder value over time. This deterioration can narrow the buffer available during operating setbacks, reduce financial flexibility, and make recovery more difficult unless profitability and cash generation improve.

Clearbridge Health Ltd. News

1H3 FAQ

What was Clearbridge Health Ltd.’s price range in the past 12 months?
Clearbridge Health Ltd. lowest share price was S$0.01 and its highest was S$0.02 in the past 12 months.
What is Clearbridge Health Ltd.’s market cap?
Clearbridge Health Ltd.’s market cap is S$6.44M.
When is Clearbridge Health Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Clearbridge Health Ltd.’s earnings last quarter?
Clearbridge Health Ltd. released its earnings results on Jul 31, 2026. The company reported S$0 earnings per share for the quarter.
Is Clearbridge Health Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Clearbridge Health Ltd. pay dividends?
Clearbridge Health Ltd. does not currently pay dividends.
What is Clearbridge Health Ltd.’s EPS estimate?
Clearbridge Health Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clearbridge Health Ltd. have?
Clearbridge Health Ltd. has 6,443,731,400 shares outstanding.
What happened to Clearbridge Health Ltd.’s price movement after its last earnings report?
Clearbridge Health Ltd. reported an EPS of S$0 in its last earnings report. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of Clearbridge Health Ltd.?
Currently, no hedge funds are holding shares in SG:1H3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology